The correlation between hepatitis C virus (HCV) genomic sequences and circulating HCV RNA levels was assessed to investigate the genetic elements affecting viral load. The interferon sensitivity-determining region (ISDR) sequence and the serum viral load were strongly correlated in 226 patients examined. Analysis of the entire HCV genome from six patients (three with a high and the others with a low viral load) with similar ISDR sequences identified several candidate residues associated with viral load. The amino acid (aa) sequences of these candidate residues and flanking regions in 67 additional patients revealed that only the residue at aa 962 varied significantly between the HCV patients with low and high serum loads (P ϭ 0.042). At this position, alanine was observed more frequently in the patients with a high viral load. In conclusion, our results strongly suggest that serum HCV RNA loads are inversely correlated with amino acid substitutions in the ISDR, and aa 962 was identified as a possible second determinant of serum HCV RNA load.
Introduction
Hepatitis C virus (HCV) 1 is one of the most important pathogens of chronic hepatitis (Major and Feinstone, 1997; Choo et al., 1989) . Chronic hepatitis C often results in liver cirrhosis and the development of hepatocellular carcinoma (Kiyosawa et al., 1990; Tong et al., 1995) and, therefore, its treatment is an important clinical issue. Currently, interferon (IFN)-based regimens, with or without ribavirin, are the only therapies that can eradicate HCV in some patients (Chayama et al., 1991; Shindo et al., 1992; Di Bisceglie and Hoofnagle, 2002) . Accordingly, the factors affecting the efficacy of IFN have been researched vigorously (Tubota et al., 1994; Mita et al., 1994; Hino et al., 1994; Pawlotsky et al., 1996; Yamada et al., 1995) . We reported that the number of amino acid substitutions in the interferon sensitivitydetermining region (ISDR) in the NS5A of HCV genotype 1b (HCV-1b) predicts the outcome of IFN therapy (Enomoto et al., 1995 (Enomoto et al., , 1996 Kurosaki et al., 1997) . Along with the number of substitutions in the ISDR, the serum HCV viral load also is reported to be an important factor predicting the effectiveness of IFN therapy (Pawlotsky, 2002) . While our previous reports demonstrated that ISDR substitution numbers correlate with serum HCV viral loads , the relationship between the two variables has not been examined in more detail. Furthermore, other than the ISDR, genomic regions of HCV that are associated with serum viral loads have not been identified.
The clarification of such sequence elements may contribute to our understanding of the mechanism of HCV replication and the nature of chronic hepatitis C.
In the present study, we examined first the correlation between the number of ISDR amino acid substitutions and circulating viral load measured by different techniques in chronic hepatitis C patients infected with HCV-1b. Subsequently, we searched for sequence elements other than the ISDR that correlate with circulating viral levels, through an analysis of six (three from patients with high and three from patients with with low viral loads) full-length HCV-1b sequences. After identification of such elements, their validity was confirmed statistically in a large group of patients with chronic hepatitis C.
Results

Relationship between the ISDR and circulating viral loads
Of the 226 patients, 108 had wild-type ISDR sequences (no amino acid substitution compared with HCV-J (Kato et al., 1990) ), 87 had the intermediate type (one to three amino acid substitutions), and 31 had the mutant type (four or more amino acid substitutions). The proportions of the three types were comparable to those in our previous report (Enomoto et al., 1996) . Fig. 1 (viral load measured by the branched DNA (bDNA) method) and Fig. 2 (viral load measured by the Amplicor method) show the relationship between the ISDR and circulating HCV viral loads. The number of amino acid substitutions in the ISDR showed a strong inverse correlation with the circulating viral load, when determined using both the bDNA method (P Ͻ 0.0001, Spearmann's rank test, Fig. 1 ) and the Amplicor method (P Ͻ 0.0001, Spearman' rank test, Fig. 2 ). Although 4 of 31 (13%) patients with the mutant type had less than 10 kcopy/ml, no patient among the 108 (0%) with the wild type had less than 10 kcopy/ml, using the Amplicor method. In contrast, although 31 of the 108 (29%) patients with the wild type had more than 10 MEq/ml, only 1 of the 31 (3%) patients with the mutant type had more than 10 MEq/ml. These results suggest that, as the number of substitutions in the ISDR increases, the serum viral load has a tendency to decrease.
However, of the patients with no or one substitution in the ISDR, no differences in viral loads were observed between the two groups using either method (P ϭ 0.13 by bDNA method, P ϭ 0.19 by Amplicor method, MannWhitney U test). Therefore, patients with no and one ISDR substitution belong to a homogeneous group with respect to circulating viral load.
Full-length HCV sequence analysis in patients with 0 or 1 amino acid substitution in the ISDR
We searched for other genomic regions of HCV that correlate with the circulating viral load. Sera from six representative patients with chronic hepatitis C attributable to HCV-1b infection and with no or one substitution in ISDR were analyzed to determine the full-length HCV sequence. This approach enabled us to exclude the effect of the ISDR on viral load and allowed us to identify other sequence elements that are related to circulating viral load. Fig. 3 shows the amino acid alignment of the ISDR from all six patients. Each has no or one amino acid substitution in the ISDR. Of these six patients, three had a high circulating viral load (Ն15 MEq/ml by the bDNA method; high-titer group), while the other group had a low circulating viral load (Ͻ0.5 MEq/ml by the bDNA method; low-titer group).
After alignment of the full-length HCV sequences, amino acid (for coding region) or nucleotide (for noncoding region) usage was compared in the high-and low-titer groups for each residue of the entire HCV genome. Between these two groups, a "complete difference" in amino acid (aa) usage was demonstrated at aa 708 (in E2, alanine in the high-titer group vs valine, serine, or threonine in the lowtiter group), aa 962 (in NS2, alanine in the high-titer group vs threonine, lysine, or valine in the low-titer group), aa 1158 (in NS3, valine in the high-titer group vs isoleucine in the low-titer group), and aa 1641 (in NS4A, isoleucine in the high-titer group vs valine in the low-titer group) (Fig. 4) . No such "complete differences" were observed in the 5Ј and 3Ј noncoding regions or X-tail.
To rule out the possibility that the four amino acid residues described above were not of significance, and to validate the relationship between these amino acid residues and the circulating viral loads, we determined the sequences flanking the four amino acids in 67 patients who had no or one substitution in the ISDR (Table 1 ). Of these, 10 patients had a low viral load (Ͻ0.5 MEq/ml). For each amino acid position, the median serum HCV RNA (by the bDNA method) was compared with respect to amino acid usage. For example, for aa 1641, the median serum HCV RNA levels were compared between patients who had isoleucine at aa 1641 and those who had valine. If patients with a valine residue had significantly smaller amounts of serum HCV RNA (confirming the initial observation), then aa 1641 would be considered to be associated with circulating viral load. Table 2 shows the results of the comparison described above. Of the four amino acid residues, amino acid usage at aa 962 correlated with serum HCV RNA level (P ϭ 0.042 by standardized Wilcoxon and Ansari-Bradley statistics). These results show that amino acid usage at aa 962 may have an impact on circulating HCV RNA loads, even after the status of ISDR amino acid substitution is corrected.
Discussion
In the present study, we analyzed initially the correlation between amino acid substitutions in the ISDR and serum viral load. Subsequently, we examined other regions that may be associated with circulating viral loads in HCV-1b infection. The findings can be summarized as two points. First, the number of substitutions in the ISDR was inversely correlated with circulating viral load. Second, in patients with no or one amino acid substitution in the ISDR, amino acid usage at aa 962 correlated with circulating viral load.
Patients with low circulating viral loads and with an HCV genotype other than 1 tend to respond to IFN therapy (Tubota et al., 1994; Kobayashi et al., 1994; Mita et al., 1994; Hino et al., 1994; Pawlotsky et al., 1996; Yamada et al., 1995) . In chronic hepatitis attributable to HCV-1b, low pretreatment circulating viral loads are closely associated with effective IFN therapy (Tubota et al., 1994; Kobayashi et al., 1994; Mita et al., 1994; Hino et al., 1994) . Meanwhile, we reported that ISDR status is an independent factor predicting an IFN effect (Enomoto et al., 1995 (Enomoto et al., , 1996 Kurosaki et al., 1997) . In Japan, most investigators have reported data similar to ours concerning the relationship between ISDR mutations and IFN efficacy (Chayama et al., 1997; Yoshioka et al., 2001 ). However, in Western countries, there have been some conflicting data (Khorsi et al., 1997; Zeuzem et al., 1997; Squadrito et al, 1997) . Recently, a meta-analysis of studies in Western countires on this subject demonstrated that a statistically significant correlation was also found between IFN efficacy and ISDR mutations by combining studies in Western counties that independently were unable to detect such a correlation, suggesting the importance of sample size (Witherell and Beineke, 2001) .
Consequently, the "mutant-type" ISDR correlates with a low viral load (Enomoto et al., 1996; Chayama et al., 1997) . Furthermore, multiple amino acid substitutions in the ISDR were detected only with low circulating viral load in a longitudinal analysis of two patients whose circulating viral loads fluctuated (Hashimoto et al., 1999) . These observations suggest that amino acid substitutions in the ISDR correlate with circulating viral level even in individual patients. In the present study, we confirmed that serum HCV RNA load is inversely correlated with the number of amino acid substitutions in the ISDR. This finding suggests that the ISDR element of NS5A affects viral replication strongly by an unknown mechanism, while some studies have demonstrated a relationship between the amino acid sequence of the ISDR and NS5A function. For example, we demonstrated a difference in the transactivator activity of NS5A according to the type of ISDR (Fukuma et al., 1998) . As another example, mutations in the ISDR were reported to affect the interaction between NS5A and PKR (dsRNAdependent protein kinase) (Gale et al., 1997) .
We demonstrated no differences in viral load between patients with no and one ISDR substitution. Most of these have an amino acid substitution at aa 2218 from histidine to arginine, both of which are basic amino acids. This result suggests that conservative substitution of aa 2218 does not have a great effect on the function of the ISDR and both histidine and arginine can be regarded essentially as same for ISDR function.
Next, we examined sequence elements other than the ISDR that may affect circulating viral loads in HCV infection. This is the first report that has analyzed full-length HCV genomes in relation to viral loads. We analyzed six full-length HCV sequences, all with functionally the same ISDR. Four candidate residues were identified and analysis revealed that only aa 962 in NS2 was closely associated V  V  11  0  53  A  A  V  I  12  0  54  V  A  V  I  13  0  55  A  A  V  I  13  0  56  A  A  I  T  13  0  57  A  A  V  I  14  0  58  A  A  V  I  14  0  59  A  A  I  V  16  0  60  A  V  V  I  17  1  61  A  A  I  I  17  1  62  A  A  L  I  20  0  63  A  T  V  I  22  1  64  A  A  I  I  27  0  65  A  A  I  I  30  1  66  V  A  V  I  Ͼ40  0  67  A  A  V  I  Ͼ40  0 with circulating viral load. This result suggests that the genomic structure of NS2 may be involved in the mechanism determining the circulating viral load. The function of NS2 has not been clarified. NS2 is a transmembrane polypeptide (Yamaga and Ou, 2002) and a component of the virally encoded protease functioning in association with the serine protease domain of NS3 (Santolini et al., 1995) . One mutation study shows that aa 952 and aa 993 of the NS2 protein are essential for the NS3-dependent cleavage between NS2 and NS3 (Grakoui et al., 1993) . Recently, we analyzed the sequence elements of HCV affecting the natural course of chronic hepatitis C. We found that aa 962 was one of seven amino acids affecting the clinical course of hepatitis C (Nagayama et al., 2000) . Specifically, patients infected with HCV-1b carrying an alanine at aa 962 suffered more frequently from advanced disease, such as hepatocellular carcinoma and liver cirrhosis, than "non-alanine" patients. In the present study, alanine at aa 962 was associated with a high viral load. This finding suggests that patients with a high circulating viral load undergo a more aggressive clinical course, although aa 962 is only one of the seven amino acids included in the count for the progression score (Nagayama et al., 2000) . More recently, Takahashi et al. (2001) also confirmed aa 962 as one of the elements contributing to the progression score, further indicating the importance of the function of NS2.
Synthesis of both the replicative intermediate minusstrand HCV RNA and the progeny positive-strand HCV RNA is thought to occur via RNA-dependent RNA polymerase (RdRp) activity in NS5B protein (Behrens et al., 1996; Yuan et al., 1997; Lohmann et al., 1997) . Thus, NS5B may be a key element in viral replication. However, in this study, we did not find any sequence elements in NS5B that were associated with circulating viral load. A precise explanation for this result is difficult, but it is possible that a major amino acid substitution in NS5B itself may make HCV replication-defective, so that it cannot survive in the host.
In conclusion, we demonstrated that the circulating viral load of HCV-1b is inversely correlated with ISDR amino acid substitutions. Furthermore, as a second sequence element, aa 962 was identified as a critical determinant of viral load by full-length sequence analysis of HCV. These clinical observations may help further in vitro studies on the mechanisms of HCV replication and release from hepatocytes.
Materials and methods
Patients
We examined prospectively 226 patients with chronic HCV infection between August 1996 and July 1998 at Musashino Red Cross Hospital. All patients were positive for serum HCV antibodies (third-generation assay) and HCV RNA of genotype 1b (Okamoto et al., 1992; Simmonds et al., 1994) . All patients were negative for serum hepatitis B surface antigen, anti-HBc antibodies, and antinuclear antibodies, and had no other causes of hepatitis including excessive alcohol intake and hepatotoxic drugs. No patient had received interferon therapy before the measurement of viral load. We analyzed serum HCV RNA levels and the ISDR amino acid sequence in these 226 patients. A branched-chain DNA (bDNA) assay (Quantiplex HCV RNA Version 1.0, Chiron, Emeryville, CA, USA) (Lau et al., 1993) and the Amplicor monitor assay (Version 1.0, Roche Diagnostic Systems, Basel, Switzerland) were used to measure circulating levels of HCV RNA. The limits of detection for these assays were 0.5 million genome equivalents per milliliter for bDNA and 1.0 kilocopies per milliliter for Amplicor monitor.
Subsequently, we determined the full-length HCV sequences detected in sera from six patients with chronic hepatitis C attributable to HCV-1b that had no or one substitution in the ISDR, to find regions other than the ISDR associated with viral load, using the experimental procedures described below. Of these patients, three had high circulating viral load (Ն15 MEq/ml by the bDNA method; high-titer group) and the other three had low viral titer (Ͻ0.5 MEq/ml by the bDNA method; low-titer group). After alignment of the six full-length sequences, amino acid usage (for the coding region) and nucleotide usage (for the noncoding regions) were compared. The frequently used amino acid/nucleotide was identified for each residue, and, if usage at a certain residue differed between the two titer groups, that residue was regarded as potentially significant for discrimination between the two groups.
After candidate residues were identified, for validation, we examined another 67 patients with chronic hepatitis C attributable to HCV-1b that had no or one amino acid substitution in the ISDR. The patients were selected randomly from the initial cohort of this study. HCV sequences flanking the candidate residues were determined and amino acid usage at each candidate residue was analyzed statistically as described below.
Sequence analysis of HCV
RNA was extracted from serum using a modified acid guanidinium-phenol-chloroform method (Chomczynski and Sacchi, 1987) using ISOGEN (Wako, Japan). Reverse transcription polymerase chain reaction (RT-PCR) was performed as described previously (Enomoto et al., 1994) . Briefly, RNA extracted from 150 l of serum was reversetranscribed to cDNA using random hexamers. The fulllength HCV genome, except the poly U stretch, was amplified with 21 partially overlapping primer sets using nested PCR. The cDNA was used for the first-round PCR. Details were shown previously (Enomoto et al., 1994) . Each PCR product was purified, and the residual primers were removed using a spin filtration column (Suprec 02, Takara, Kyoto, Japan) according to the manufacturer's instructions. Thereafter, both strands of the PCR products were cyclesequenced using a PRISM dye termination kit (CN402069, Applied Biosystems, Japan) according to the manufacturer's instruction. The sequencing primers were the M13 forward primer for the sense strand and the M13 reverse primer for the antisense strand. The products were purified using a Quickspin column (Boeringer-Mannheim, Indianapolis, IN, USA) and sequenced automatically (Model 373S, Applied Biosystems Japan). Nucleotide and predicted amino acid sequences, including the ISDR, were compared with the sequence of HCV-J (Kato et al., 1990 ) as a reference. Types of ISDR (wild, intermediate, and mutant type) were defined as in our previous report (Enomoto et al., 1996) . Sequencing was performed in duplicate. This ruled out the possibility of misincorporation of nucleotides during PCR.
Statistical analysis
Distributions of continuous variables were analyzed using standardized Wilcoxon and Ansari-Bradley statistics (Lepage's test) (Lepage, 1971; Hirakawa, 1974) . The correlation between the number of amino acid substitutions in NS5A and serum HCV RNA level was examined by Spearman's rank correlation test using Statview 5.0 software (Abacus Concepts, Berkeley, CA, USA). All tests of significance were two-tailed and P values less than 0.05 were considered to be statistically significant.
